| 注册
首页|期刊导航|广州医药|肿瘤微环境响应型多柔比星前药的研究进展

肿瘤微环境响应型多柔比星前药的研究进展

王悦 马文静 侯金松 吴豪

广州医药2025,Vol.56Issue(9):1189-1200,12.
广州医药2025,Vol.56Issue(9):1189-1200,12.DOI:10.20223/j.cnki.1000-8535.2025.09.005

肿瘤微环境响应型多柔比星前药的研究进展

Research progress of doxorubicin prodrug based on tumor microenvironment response

王悦 1马文静 1侯金松 1吴豪1

作者信息

  • 1. 滁州学院材料与化学工程学院(安徽 滁州 239000)
  • 折叠

摘要

Abstract

Compared with normal tissue cell microenvironment,there is some differences in tumor microenvironment,such as partial acidity,imbalance of redox state,high concentration of reactive oxygen species and cathepsin.According to the above characteristics of tumor microenvironment,a series of small molecule or polymer prodrug nanoparticles connected by various special microenvironment responsive structures can be designed.Doxorubicin,as one of the most common broad-spectrum antitumor drugs,plays an important role in the treatment of tumors.This review discusses the doxorubicin prodrug designed for different tumor microenvironments under the physiological state of tumor microenvironment specificity and their release characteristics,and summarizes the research progress of tumor microenvironment-responsive doxorubicin prodrug.

关键词

肿瘤微环境/多柔比星前药/肿瘤治疗/谷胱甘肽/活性氧

Key words

tumor microenvironment/doxorubicin prodrug/tumor therapy/glutathione/reactive oxygen species

引用本文复制引用

王悦,马文静,侯金松,吴豪..肿瘤微环境响应型多柔比星前药的研究进展[J].广州医药,2025,56(9):1189-1200,12.

基金项目

安徽省教育厅高校科学研究一般项目(KJ2021B16) (KJ2021B16)

广州医药

1000-8535

访问量0
|
下载量0
段落导航相关论文